Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

Completed · Not applicable · Has a placebo group

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Tetracycline may be effective in preventing skin rash that is caused by treatment with drugs such as gefitinib or cetuximab. PURPOSE: This randomized clinical trial is studying tetracycline to see how well it works compared to placebo in preventing skin rash in patients who are receiving drugs such as gefitinib or cetuximab for cancer.

Key facts

Study ID
NCT00091247
Run by
Alliance for Clinical Trials in Oncology
People needed
130
Starts
2004-12-01
Expected to finish
2009-07-01
Last updated by the study team
2017-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.